These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 35700043)

  • 1. Myeloid FoxO1 depletion attenuates hepatic inflammation and prevents nonalcoholic steatohepatitis.
    Lee S; Usman TO; Yamauchi J; Chhetri G; Wang X; Coudriet GM; Zhu C; Gao J; McConnell R; Krantz K; Rajasundaram D; Singh S; Piganelli J; Ostrowska A; Soto-Gutierrez A; Monga SP; Singhi AD; Muzumdar R; Tsung A; Dong HH
    J Clin Invest; 2022 Jul; 132(14):. PubMed ID: 35700043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis.
    Wang Q; Zhou H; Bu Q; Wei S; Li L; Zhou J; Zhou S; Su W; Liu M; Liu Z; Wang M; Lu L
    J Hepatol; 2022 Aug; 77(2):312-325. PubMed ID: 35292349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cenicriviroc Suppresses and Reverses Steatohepatitis by Regulating Macrophage Infiltration and M2 Polarization in Mice.
    Chen G; Yu Y; Zhu Y; Nagashimada M; Wang Y; Nagata N; Xu L
    Endocrinology; 2024 May; 165(7):. PubMed ID: 38862137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis.
    Liu C; Schönke M; Spoorenberg B; Lambooij JM; van der Zande HJP; Zhou E; Tushuizen ME; Andreasson AC; Park A; Oldham S; Uhrbom M; Ahlstedt I; Ikeda Y; Wallenius K; Peng XR; Guigas B; Boon MR; Wang Y; Rensen PCN
    Elife; 2023 Jan; 12():. PubMed ID: 36648330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Honokiol attenuates diet-induced non-alcoholic steatohepatitis by regulating macrophage polarization through activating peroxisome proliferator-activated receptor γ.
    Zhong X; Liu H
    J Gastroenterol Hepatol; 2018 Feb; 33(2):524-532. PubMed ID: 28670854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Foxo1-YAP-Notch1 axis reprograms STING-mediated innate immunity in NASH progression.
    Xu D; Qu X; Yang T; Sheng M; Bian X; Zhan Y; Tian Y; Lin Y; Jin Y; Wang X; Ke M; Jiang L; Li C; Xia Q; Farmer DG; Ke B
    Exp Mol Med; 2024 Aug; 56(8):1843-1855. PubMed ID: 39122845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
    Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L
    Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
    Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
    J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and reversal of lipotoxicity-induced hepatic insulin resistance and steatohepatitis in mice by an antioxidant carotenoid, β-cryptoxanthin.
    Ni Y; Nagashimada M; Zhan L; Nagata N; Kobori M; Sugiura M; Ogawa K; Kaneko S; Ota T
    Endocrinology; 2015 Mar; 156(3):987-99. PubMed ID: 25562616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of FoxO1 ameliorates hepatic steatosis and hepatitis in nonalcoholic steatohepatitis mice through regulation of gut microbiota.
    Shou DW; Quan Y; Cheng JM; Yang SQ; Chen JW; Li YQ; Huang C; Chen HT; Zhou YJ
    J Dig Dis; 2024 Jul; 25(7):453-462. PubMed ID: 39211938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 is a key player in non-alcoholic steatohepatitis.
    Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
    J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p16 INK4A drives nonalcoholic fatty liver disease phenotypes in high fat diet fed mice through biliary E2F1/FOXO1/IGF-1 signaling.
    Kundu D; Kennedy L; Zhou T; Ekser B; Meadows V; Sybenga A; Kyritsi K; Chen L; Ceci L; Wu N; Wu C; Glaser S; Carpino G; Onori P; Gaudio E; Alpini G; Francis H
    Hepatology; 2023 Jul; 78(1):243-257. PubMed ID: 36799449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival.
    Mridha AR; Haczeyni F; Yeh MM; Haigh WG; Ioannou GN; Barn V; Ajamieh H; Adams L; Hamdorf JM; Teoh NC; Farrell GC
    Clin Sci (Lond); 2017 Aug; 131(16):2145-2159. PubMed ID: 28687713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid-specific fatty acid transport protein 4 deficiency induces a sex-dimorphic susceptibility for nonalcoholic steatohepatitis in mice fed a high-fat, high-cholesterol diet.
    Göcebe D; Jansakun C; Zhang Y; Staffer S; Tuma-Kellner S; Altamura S; Muckenthaler MU; Merle U; Herrmann T; Chamulitrat W
    Am J Physiol Gastrointest Liver Physiol; 2023 May; 324(5):G389-G403. PubMed ID: 36881564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise of high intensity ameliorates hepatic inflammation and the progression of NASH.
    Fredrickson G; Barrow F; Dietsche K; Parthiban P; Khan S; Robert S; Demirchian M; Rhoades H; Wang H; Adeyi O; Revelo XS
    Mol Metab; 2021 Nov; 53():101270. PubMed ID: 34118476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage-derived Osteopontin (SPP1) Protects From Nonalcoholic Steatohepatitis.
    Han H; Ge X; Komakula SSB; Desert R; Das S; Song Z; Chen W; Athavale D; Gaskell H; Lantvit D; Guzman G; Nieto N
    Gastroenterology; 2023 Jul; 165(1):201-217. PubMed ID: 37028770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of C5aR1 alleviates liver inflammation and fibrosis in a mouse model of NASH by regulating TLR4 signaling and macrophage polarization.
    Jiang K; Lu S; Li D; Liu M; Jin H; Lei B; Wang S; Long K; He S; Zhong F
    J Gastroenterol; 2023 Sep; 58(9):894-907. PubMed ID: 37227481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCL10-Mediates Macrophage, but not Other Innate Immune Cells-Associated Inflammation in Murine Nonalcoholic Steatohepatitis.
    Tomita K; Freeman BL; Bronk SF; LeBrasseur NK; White TA; Hirsova P; Ibrahim SH
    Sci Rep; 2016 Jun; 6():28786. PubMed ID: 27349927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gliptins Suppress Inflammatory Macrophage Activation to Mitigate Inflammation, Fibrosis, Oxidative Stress, and Vascular Dysfunction in Models of Nonalcoholic Steatohepatitis and Liver Fibrosis.
    Wang X; Hausding M; Weng SY; Kim YO; Steven S; Klein T; Daiber A; Schuppan D
    Antioxid Redox Signal; 2018 Jan; 28(2):87-109. PubMed ID: 28635324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.